News / Finance
Todays Most Active Stock - (NASDAQ:DNDN) - Online Stock Alert
Free Stock Market Alert
Dendreon Corporation (NASDAQ:DNDN) climbed 6.51% to $27.288 on 1.50 million shares within few minutes of trade after it added two new directors to its board, including Ian Clark, the current chief executive of Roche's Genentech unit. Before the Roche acquisition, Clark served as Genentech's chief commercial officer.
Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that improve cancer treatment options for patients. Dendreon’s most advanced product candidate is Provenge (sipuleucel-T), an active cellular immunotherapy that has completed two Phase III trials for the treatment of asymptomatic, metastatic, androgen-independent prostate cancer.
ABOUT PennyStockPickReport.com
Penny Stock Pick Report is one of the leading stock web site that provides free stock alerts and tracks small cap penny stocks that could be on the brink of a massive breakout. If you wish to get your company featured on our website then please contact us at info[at]PennyStockPickReport.
